Biocon remits final dividend of Re 0.50/share for FY 2025-26

Corporate Actions View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹412.90

prior close

₹411.10

announcement price

After-mkt

timing

Nifty Midcap 150market+0.1%-0.3% vs market

Pharmaceuticals peers, median of 174sector-0.3%+0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Midcap 150 and 0.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.8

15m

-0.6

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2+0.1-0.3-0.3+0.1

Next day

-2.7-1.1-1.6-0.7-2.0

-2.8-1.7-1.1-0.4-2.4

-2.6-1.2-1.4-0.2-2.4

-4.0-1.4-2.5-0.0-3.9

-5.2-1.9-3.3+0.0-5.2

-4.3-2.2-2.1+0.1-4.4

15d

-5.5-3.1-2.5+0.2-5.8

-10.3-7.0-3.3+0.0-10.3

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon Limited has remitted the final dividend of Re 0.50 per equity share (face value Re 5) for FY 2025-26, approved by shareholders at the 48th AGM on August 6, 2026. Record date was July 3, 2026. Dividends were credited electronically to shareholder bank accounts per their mandates registered with KFin Technologies, the company's RTA.

Likely market impact

Routine dividend credit to eligible shareholders. Already approved at AGM, so no new catalyst; modest per-share payout.